Spatial mapping of Ethiopian cutaneous leishmaniasis lesions reveals distinct tissue level immune programs - Summary - MDSpire

Geospatial Analysis of Cutaneous Leishmaniasis Lesions in Ethiopia Uncovers Unique Immune Response Patterns at the Tissue Level

  • By

  • Nidhi S. Dey

  • Thao-Thy Pham

  • Shoumit Dey

  • Mekibib Kassa

  • Tigist Mekonnen

  • Helina Fikre

  • Pieter Monsieurs

  • Spatial CL Consortium

  • Myrthe Pareyn

  • Johan van Griensven

  • Malgorzata Domagalska

  • Jean-Claude Dujardin

  • Mezgebu Silamsaw Asres

  • Mikias Woldetensay

  • Paul M. Kaye

  • Wim Adriaensen

  • July 21, 2026

Share

Objective:

To characterize the immune response at the lesional level in patients presenting with cutaneous leishmaniasis (CL) in Ethiopia using spatial transcriptomics.

Approach:
  • Study Design: Exploratory study using spatial transcriptomics on paired lesional and non-lesional skin punch biopsies from five Ethiopian CL patients.
  • Methods: Reference-free deconvolution, morphology-guided regional analyses, and immunohistochemistry-based validation were employed to characterize tissue responses.
Key Findings:
  • Identified spatially distinct immunopathological tissue responses including: i) epithelial hyperplasia with interferon-stimulated keratinocytes, ii) cytotoxicity with tertiary lymphoid structures, iii) granulomatous inflammation with proinflammatory response, iv) granulomatous inflammation with M2-polarised myeloid cell responses, and v) fibrotic remodelling with active collagen synthesis.
  • Each patient in this case series exemplified one of these tissue responses, but immunopathological features were not mutually exclusive.
  • This study extends our understanding of Ethiopian CL immunopathology and provides a molecular and cellular context that can be applied in larger clinical cohorts for testing hypotheses regarding the host and/or parasite determinants of CL disease diversity.
Interpretation:

The study provides insights into the immune responses in Ethiopian CL, highlighting the complexity of the disease.

Limitations:
  • Small sample size of five patients limits generalizability.
  • Exploratory nature of the study may not capture the full spectrum of immune responses.
Conclusion:

This study enhances the understanding of the immunopathological landscape of cutaneous leishmaniasis in Ethiopia and sets the stage for larger clinical studies.

Original Source(s)

Related Content